Antibodies (ISSN 2073-4468), an international, peer-reviewed open access journal which provides an advanced forum for studies related to antibodies and antigens, especially how to quickly translate basic research results to therapeutic applications. It publishes reviews, research articles, communications and short notes. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Antibodies is covered by Emerging Sources Citation Index (ESCI) and DOAJ.
Cell and Gene Therapy Insights is an online, open access, peer-reviewed journal with a translational focus. Key scientific, regulatory, business and manufacturing challenges and advances are addressed through publication of original research, editorials and interviews. These are complimented by daily news, webinars, and commercial and clinical trial updates.
All content is available free of charge, and you can register at www.insights.bio/cell-and-gene-therapy-insights.
Gene Therapy Net
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines
MabDesign is a French non-profit membership organization that aims to federate, mobilize and support the development of the industrial sector in the field of immunotherapy.
MabDesign provides strategic leverage and development opportunities for its members, through the creation of a unique directory of stakeholders; by developing specialized training solutions, by providing ...
RegMedNet is a free community network that unites all members of the diverse regenerative medicine field, covering the latest news, providing educational resources and expert comment and enabling them to share the latest news, inspiration and insights to help this exciting field move forward at an even faster rate.
Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.